(19)
(11) EP 3 934 640 A1

(12)

(43) Date of publication:
12.01.2022 Bulletin 2022/02

(21) Application number: 20766948.2

(22) Date of filing: 06.03.2020
(51) International Patent Classification (IPC): 
A61K 31/23(2006.01)
A61P 1/16(2006.01)
 A61K 31/231(2006.01)
A23L 33/115(2016.01)
(52) Cooperative Patent Classification (CPC):
A61P 1/16; A61K 45/06; A61K 31/575; A23L 33/115; A61K 31/231
 
C-Sets:
  1. A61K 31/231, A61K 2300/00;
  2. A61K 31/575, A61K 2300/00;
(86) International application number:
PCT/IB2020/051990
(87) International publication number:
WO 2020/178803 (10.09.2020 Gazette 2020/37)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.03.2019 KR 20190026326
18.07.2019 KR 20190086967
30.09.2019 US 201962908392 P

(71) Applicant: Enzychem Lifesciences Corporation
Seoul, 137-73 (KR)

(72) Inventors:
  • SOHN, Ki Young
    Seoul (KR)
  • KIM, Jae Wha
    Daejeon (KR)
  • YOON, Sun Young
    Daejeon (KR)

(74) Representative: Forstmeyer, Dietmar 
BOETERS & LIECK Oberanger 32
80331 München
80331 München (DE)

   


(54) COMPOSITION COMPRISING MONOACETYLDIACYLGLYCEROL COMPOUND FOR TREATING FATTY LIVER DISEASE